CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigator Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
35,156 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0323

Benzaldehyde CAS 100-52-7

Filed under Raw Materials. The bureau holds 132 laboratory returns for this compound from 39 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

39 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
HomopeptideCASE #VI-2026-0760 A 7 10.0 9.9 10.0 24 May 2026 24 May 2026
Tianjin Finder Chemical TFCCASE #VI-2026-0693 A 6 10.0 9.9 10.0 14 Nov 2025 16 Apr 2026
Kerui PeptidesCASE #VI-2026-0626 A 4 10.0 9.9 10.0 8 Jan 2026 22 Mar 2026
Hubei JianxiangCASE #VI-2026-0048 A 4 10.0 9.9 10.0 7 Nov 2025 4 Jul 2026
Flourishglobal PeptideCASE #VI-2026-0630 A 3 10.0 9.9 10.0 7 Mar 2026 24 Jun 2026
GenScript PeptidesCASE #VI-2026-0860 A 3 10.0 9.9 10.0 27 Feb 2026 16 Aug 2026
Sigma-AldrichCASE #VI-2026-0829 A 3 10.0 10.0 10.0 25 Apr 2026 21 Jul 2026
AsymchemCASE #VI-2026-0091 A 3 10.0 9.9 10.0 11 Jun 2026 18 Jul 2026
Shanghai ERP BiotechnologyCASE #VI-2026-0936 A 2 10.0 10.0 10.0 2 Nov 2025 13 Apr 2026
QYAOBIOCASE #VI-2026-0861 A 4 9.9 9.9 10.0 25 Mar 2026 4 Jul 2026
JEEP PeptidesCASE #VI-2026-0457 A 4 9.9 9.9 10.0 3 May 2026 11 Jul 2026
BachemCASE #VI-2026-0314 A 4 9.9 9.9 10.0 9 Mar 2026 6 Jun 2026
Mokemei BiotechnologyCASE #VI-2026-0540 A 4 9.9 9.9 10.0 14 Dec 2025 10 Jul 2026
Shanghai Wibson BiotechnologyCASE #VI-2026-0379 A 4 9.9 9.9 10.0 26 Mar 2026 8 Jun 2026
Hybio PharmaceuticalCASE #VI-2026-0065 A 4 9.9 9.9 10.0 16 Jun 2026 17 Aug 2026
Thermo Fisher ScientificCASE #VI-2026-0142 A 4 9.9 9.9 9.9 12 Feb 2026 24 Jul 2026
WuXi TIDESCASE #VI-2026-0335 A 3 9.9 9.9 10.0 23 Nov 2025 6 May 2026
Sangon BioCASE #VI-2026-0671 A 2 9.9 9.9 9.9 2 Nov 2025 7 Dec 2025
Chinese Peptide CompanyCASE #VI-2026-0184 A 2 9.9 9.9 10.0 10 Mar 2026 6 Apr 2026
Shanghai Sigma AudleyCASE #VI-2026-0505 A 2 9.9 9.9 10.0 2 Apr 2026 24 Jul 2026
PolyPeptide GroupCASE #VI-2026-0143 A 2 9.9 9.9 9.9 6 Aug 2026 6 Aug 2026
SinoPepCASE #VI-2026-0387 A 2 9.9 9.9 10.0 24 Apr 2026 9 Jul 2026
AmbioPharmCASE #VI-2026-0177 A 2 9.9 9.9 9.9 28 Jan 2026 22 Apr 2026
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 A 2 9.2 8.4 10.0 24 May 2026 24 May 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538 A 4 9.1 8.2 10.0 24 May 2026 24 May 2026
UtherCASE #VI-2026-0902 X 5 9.0 7.2 10.0 17 Dec 2024 24 May 2026
Shanghai Sigma Audley SSACASE #VI-2026-0486 A 6 8.5 7.9 10.0 21 May 2026 21 May 2026
Glbiochem (Shanghai)CASE #VI-2026-0704 A 8 8.4 7.1 9.4 24 May 2026 24 May 2026
Pura PeptidesCASE #VI-2026-0307 X 1 8.4 8.4 8.4 3 Jun 2025 3 Jun 2025
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 A 7 7.7 6.6 8.7 24 May 2026 24 May 2026
Bfflist AMOCASE #VI-2026-0678 X 3 7.3 5.8 10.0 27 Feb 2025 24 May 2026
HXNetCASE #VI-2026-0061 X 9 7.2 3.6 9.7 24 Apr 2025 17 May 2026
Biolongevity LabsCASE #VI-2026-0442 X 3 6.7 4.9 8.1 9 Jun 2025 17 May 2026
Zztai PeptideCASE #VI-2026-0192 X 1 6.2 6.2 6.2 6 May 2025 6 May 2025
Hangzhou Mandy BiotechnologyCASE #VI-2026-0695 X 1 5.8 5.8 5.8 3 Jul 2025 3 Jul 2025
PurePeptidesCASE #VI-2026-0234 X 1 5.0 5.0 5.0 6 May 2025 6 May 2025
Shaanxi Dideu MedichemCASE #VI-2026-0499 X 1 4.7 4.7 4.7 25 Apr 2025 25 Apr 2025
Richards Biotech Simply RichardsCASE #VI-2026-0307 X 1 4.2 4.2 4.2 25 Apr 2025 25 Apr 2025
Coffee and PeppersCASE #VI-2026-0274 X 1 0.0 0.0 0.0 8 Jul 2025 8 Jul 2025

Open any subject to view the batch-level evidence for Benzaldehyde CAS 100-52-7 alone.